InsiderTrades.com logo
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

BVXP Insider Trading

Insider Ownership Percentage: 8.08%
Insider Buying (Last 12 Months): £676.09
Insider Selling (Last 12 Months): £2,663,819.76

Bioventix Insider Trading History Chart

This chart shows the insider buying and selling history at Bioventix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bioventix Share Price & Price History

Current Price: GBX 4,450
Price Change: ▲ Price Increase of +25 (0.56%)
As of 04/26/2024 01:00 AM ET

This chart shows the closing price history over time for BVXP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

Bioventix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2024Peter John HarrisonInsiderSell62,000GBX 4,200£2,604,000
11/27/2023Bruce HiscockInsiderBuy17GBX 3,977£676.09
5/18/2023Ian James NicholsonInsiderSell1,638GBX 3,652£59,819.76
4/24/2023Bruce HiscockInsiderBuy11GBX 3,823£420.53
1/31/2023Peter John HarrisonInsiderSell57,558GBX 3,750£2,158,425
11/21/2022Bruce HiscockInsiderBuy50GBX 3,724£1,862
10/26/2022Bruce HiscockInsiderSell204GBX 3,341£6,815.64
4/25/2022Bruce HiscockInsiderBuy3GBX 3,500£105
10/18/2021Bruce HiscockInsiderBuy204GBX 3,855£7,864.20
See Full Table
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Bioventix (LON:BVXP)

62.90% of Bioventix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bioventix logo
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Read More on Bioventix

Today's Range

Now: GBX 4,450
Low: 4,415
High: 4,474

50 Day Range

MA: GBX 4,675.72
Low: 4,406
High: 5,065

52 Week Range

Now: GBX 4,450
Low: 3,402
High: 5,100

Volume

1,387 shs

Average Volume

5,689 shs

Market Capitalization

£232.29 million

P/E Ratio

2,730.06

Dividend Yield

3.43%

Beta

0.36

Who are the company insiders with the largest holdings of Bioventix?

Bioventix's top insider shareholders include:
  1. Bruce Hiscock (Insider)
  2. Ian James Nicholson (Insider)
  3. Peter John Harrison (Insider)
Learn More about top insider investors at Bioventix.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
From Behind the Markets   |   Ad
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Get the name of the stock here >>>